Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Charles Schwab Q1 Net Profit Up, But EPS Flat - Quick Facts

RELATED NEWS
Trade SCHW now with 

Brokerage and investment manager Charles Schwab Corp. (SCHW: Quote) reported higher first-quarter net income available to common stockholders of $198 million, versus $195 million a year ago, with earnings per share remaining flat at $0.15 per share. Also, quarterly net income grew 6% to $206 million, from the prior-year quarter's $195 million.

On average, 23 analysts polled by Thomson Reuters expected earnings per share of $0.16 for the quarter. Analysts' estimates typically exclude one-time items.

Total net revenues were $1.29 billion in the first quarter, up 8% from $1.19 billion last year, while it beat consensus estimate of $1.27 billion.

Click here to receive FREE breaking news email alerts for Charles Schwab and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.